Abstract:ID 130331 Poster Board 542 AIMS: Sirtuin 3 (SIRT3) is a mitochondrial-localized deacetylase associated with aging diseases, including heart failure. Our lab has previously discovered that cardiomyocyte-specific knockout of SIRT3 (SIRT3cKO) in mice leads to heart failure characterized by activation of the ferroptosis cell death pathway. We hypothesized that the ferroptosis inhibitor Ferrostatin-1 (Fer-1) would improve cardiac function in SIRT3cKO mice via improving mitochondrial dysfunction seen in this model. METHODS AND RESULTS: SIRT3loxp wild-type (WT) and SIRT3cKO mice were treated with Ferrostatin-1 via intraperitoneal injection at a dose of 1mg/kg body weight/day for 14 days. Transthoracic echocardiography revealed that SIRT3cKO mice had decreased ejection fraction and fractional shortening, alongside an increased isovolumic relaxation time, isovolumic contraction time, and myocardial performance index, and a decreased E/E' ratio compared to the WT. Treatment with Fer-1 led to an increased ejection fraction and fractional shortening, as well as an improved isovolumic contraction time and myocardial performance index in SIRT3cKO mice. Mitochondrial function analysis demonstrated that SIRT3cKO mice have a decreased mitochondrial membrane potential, which is significantly improved following Fer-1 treatment. Furthermore, SIRT3cKO mice exhibit decreased mitochondrial Complex I and Complex IV activities. Fer-1 treatment increased Complex IV activity in SIRT3cKO mice. Mitochondrial aconitase activity and mitochondrial calcium content were also significantly decreased in SIRT3cKO mice and were ameliorated following Fer-1 treatment. CONCLUSIONS: Fer-1 rescues cardiac dysfunction in SIRT3cKO mice by improving mitochondrial membrane potential and Complex IV activity, as well as normalizing mitochondrial aconitase activity and calcium levels. This study demonstrates for the first time that Fer-1 specifically targets mitochondrial function to reverse cardiac dysfunction, suggesting that Fer-1 may be a potential therapeutic for use in the treatment of heart failure. Funding: This work was supported by the National Institute of General Medical Sciences and National Heart, Lung, and Blood Institute (R01HL151536, JX Chen), the National Heart, Lung, and Blood Institute (R56HL164321, H.Z) and University of Mississippi Medical Center Intramural Research Support Program (IRSP, H.Z.).

SRT1720 ALLEVIATES ENDOTHELIAL CRIF1 DEFICIENCY-INDUCED CARDIAC FUNCTION

Metabolomic and transcriptomic studies of improvements in myocardial infarction due to Pycr1 deletion

RTA 408 Ameliorates Diabetic Cardiomyopathy by Activating Nrf2 to Regulate Mitochondrial Fission and Fusion and Inhibiting NF-κB-mediated Inflammation.

Abstract 10153: SIRT1 Activation Restores Cardioprotection in the Aged Heart Against Ischemia/Reperfusion Injury

CHK1 Attenuates Cardiac Dysfunction Via Suppressing SIRT1-ubiquitination

Abstract 4134837: Checkpoint Kinase 1 Attenuates Myocardial Ischemia-Reperfusion Injury Through Maintaining SIRT1-Dependent Mitochondrial Homeostasis

The Mechanism of SIRT3 Regulating SRV2-Mediated Mitochondrial Fission of Fibroblasts to Inhibit Myocardial Fibrosis after Acute Myocardial Infarction

Chronic SIRT1 supplementation in diabetic mice improves endothelial function by suppressing oxidative stress

Abstract 525: Adult Inducible Deletion of Endothelial Hypoxia-inducible Factor-2α Exaggerates Myocardial Infarction Induced Heart Failure and Cardiac Microvascular Barrier Dysfunction

Ferrostatin-1 Targets Mitochondrial Function to Improve Heart Failure in a Cardiomyocyte-Specific SIRT3 Knockout Mouse Model

Abstract P3094: Mir-181c-5p As Detrimental Player In A Mouse Model Of Cardiorenal Syndrome With Thrombotic Microangiopathy

Selective enhancement of cardiomyocyte efficiency results in a pernicious heart condition

SIRT1-dependent PGC-1α deacetylation by SRT1720 rescues progression of atherosclerosis by enhancing mitochondrial function

Ckip-1 3'UTR alleviates prolonged sleep deprivation induced cardiac dysfunction by activating CaMKK2/AMPK/cTNI pathway

Elevated SLC40A1 impairs cardiac function and exacerbates mitochondrial dysfunction, oxidative stress, and apoptosis in ischemic myocardia

SIRT1 is Required for Exercise-Induced Beneficial Effects on Myocardial Ischemia/Reperfusion Injury

Ferrostatin-1 specifically targets mitochondrial iron-sulfur clusters and aconitase to improve cardiac function in Sirtuin 3 cardiomyocyte knockout mice

Abstract 1606: A Novel Cardiac-Specific Isoform of the Cell Cycle-Related Kinase Provides Cardioprotection During Myocardial Ischemia

Abstract P3187: Deletion Of SARM1 NAD Hydrolase Ameliorates Diabetic Cardiomyopathy By Regulating Mitochondrial Metabolism And Mitophagy

CTRP3 alleviates mitochondrial dysfunction and oxidative stress injury in pathological cardiac hypertrophy by activating UPRmt via the SIRT1/ATF5 axis

Sirt5 preserves cardiac function in ischemia-reperfusion injury by inhibiting ANT2 lactylation